Corindus Vascular Robotics, which sells robotic systems that aid stent placement during coronary angioplasties, raised $42 million on Thursday night by offering 11 million shares at $3.80.
The company's stock had been trading on the OTCQB under the symbol CVRS at $4.25 when Corindus set terms on Tuesday for the public offering. Its shares had fallen to $4.00 on Friday on low volume.
Primary shareholders include HealthCor Partners Management (38% post-IPO stake), Koninklijke Philips (18%), Robert Smith (9%), 20/20 Capital (6%) and CEO David Handler (3%).
Corindus Vascular Robotics listed its shares on the NYSE MKT under the symbol CVRS. Cowen & Company and Stifel acted as lead managers on the deal.
